Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.16 USD | -0.95% |
|
+0.48% | -72.54% |
20/06 | UBS Downgrades Zentalis Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $28 | MT |
18/06 | US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.54% | 30Cr | |
+16.49% | 12TCr | |
+21.73% | 12TCr | |
+22.65% | 2.66TCr | |
-21.81% | 1.99TCr | |
-16.75% | 1.63TCr | |
-18.81% | 1.55TCr | |
-44.74% | 1.55TCr | |
+62.72% | 1.48TCr | |
+3.09% | 1.37TCr |
- Stock Market
- Equities
- ZNTL Stock
- News Zentalis Pharmaceuticals, Inc.
- Pfizer Taking $25 Million Stake in Zentalis Pharmaceuticals; Companies Will Collaborate on Clinical Development